Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
September 5, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for March 21, 2006 Subscribe to this News Feed      
 

Studies Show Cellulean® Micronizes Fat and Cellulite in Women

UCLA study shows women’s thighs shrink 1 1/2 inches with cream containing common asthma medication.
We love getting testimonials from women who are blown away with the results they see in the first few weeks.

Diamond Bar, CA (PRWEB) March 21, 2006 -- Micronizing fat cells just got easier for women desiring thin legs, according to UCLA studies demonstrating successful localized fat reduction in women’s thighs by applying (Cellulean®) aminophylline cream twice daily, losing as much as an inch and a half in thirty days.

LogoforPressRelease.jpg

U.S. privately owned Cellulean® cream contains 2% aminophylline, a prescription asthma medication, now clinically proven to assist in micronizing unwanted fat from women's thighs. Cellulean® is retailed over the counter without a prescription, in doctor’s offices, cosmetic clinics, health spas, and over the Internet. "Aminophylline produces tissue specific enhancement in fat reduction, without side effects”, states Dr. F. Greenway, discoverer of aminpohylline in topical fat reduction at UCLA.    

“Women love Cellulean®, in fact they joke around about wanting to bathe in it!” exclaims Patrick Leddy, President of Cellulean®. “My legs are smoother and thinner… people notice the change”, smiles Sherry Lantz, a happy Cellulean® customer in recent TV news interview. Patrick goes on to say, “We love getting testimonials from women who are blown away with the results they see in the first few weeks.”

In 2005, CBS News Philadelphia conducted its own thirty day study on Cellulean’s® effectiveness before reporting Cellulean® on its evening news broadcast. The woman’s thighs being tested shrank two inches in thirty days, they reported.    

The fast working cream is applied twice daily like lotion to the problem areas of the body where it works to help visually shrink the unwanted fat. Cellulean® absorbs quickly so clothing can be put on shortly after applying.

Cellulean® is currently offering a free 30 day trial for first time customers at www.cellulean.com. An 8oz bottle, 30 day supply of Cellulean retails for $59.95

For more information,
Contact: Patrick Leddy
President, Cellulean.com
Tel: 1-866-622-3550

####

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1Db3VwLVNxdWEtVGhpci1IYWxmLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Patrick Leddy
MWT, INC.
9098617849
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright